ArticleFrontiers in pharmacology2021

Immune Checkpoint Inhibitor-Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study.

Li Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.